Literature DB >> 17563131

Successful treatment of propafenone, digoxin and warfarin overdosage with plasma exchange therapy and rifampicin.

Sule Unal1, Benan Bayrakci, Umit Yasar, Tevfik Karagoz.   

Abstract

We report here the successful treatment of a 16-year-old female who ingested 20 tablets of digoxin each containing 0.25 mg (total dose ingested equivalent to 0.1 mg/kg), 32 tablets of warfarin each containing 5mg (equivalent to 3.2 mg/kg), and approximately 15 tablets of propafenone each containing 300 mg (equivalent to 90 mg/kg). The patient developed hypotension and sinus bradycardia necessitating external cardiac pacing 17 hours after drug ingestion. In addition to gastric lavage, activated charcoal, blood alkalinisation, administration of vitamin K and temporary cardiac pacing, the authors performed plasma exchange for drug removal and administered rifampicin in order to increase the metabolism of digoxin, propafenone and warfarin. The patient was discharged without any sequelae. Plasma exchange may be lifesaving in drug ingestions where there is a low volume of distribution and high plasma protein binding. Rifampicin, an inducer of cytochrome p450, may be used in intoxications for elimination of drugs with inactive metabolites.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17563131     DOI: 10.2165/00044011-200727070-00008

Source DB:  PubMed          Journal:  Clin Drug Investig        ISSN: 1173-2563            Impact factor:   2.859


  18 in total

1.  Plasma exchange for the removal of digoxin-specific antibody fragments in renal failure: timing is important for maximizing clearance.

Authors:  M Zdunek; A Mitra; M H Mokrzycki
Journal:  Am J Kidney Dis       Date:  2000-07       Impact factor: 8.860

Review 2.  Haemolytic-uraemic syndrome and thrombotic thrombocytopenic purpura--new insights into underlying biochemical mechanisms.

Authors:  M Furlan; B Lämmle
Journal:  Nephrol Dial Transplant       Date:  2000-08       Impact factor: 5.992

3.  Therapeutic apheresis: a summary of current indication categories endorsed by the AABB and the American Society for Apheresis.

Authors:  James W Smith; Robert Weinstein; Krista L Hillyer
Journal:  Transfusion       Date:  2003-06       Impact factor: 3.157

4.  Interaction between warfarin and propafenone in healthy volunteer subjects.

Authors:  R E Kates; Y G Yee; E B Kirsten
Journal:  Clin Pharmacol Ther       Date:  1987-09       Impact factor: 6.875

5.  Therapeutic plasma exchange in patients with chylomicronemia syndrome complicated by acute pancreatitis.

Authors:  A Lennertz; K G Parhofer; W Samtleben; T Bosch
Journal:  Ther Apher       Date:  1999-08

6.  Therapeutic plasma exchange in patients suffering from thrombotic microangiopathy after allogeneic bone marrow transplantation.

Authors:  T Bosch; R Buhmann; A Lennertz; W Samtleben; H J Kolb
Journal:  Ther Apher       Date:  1999-08

Review 7.  Therapeutic plasma exchange in the intensive care setting.

Authors:  W Samtleben; N Mistry-Burchardi; B Hartmann; A Lennertz; T Bosch
Journal:  Ther Apher       Date:  2001-10

Review 8.  Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis.

Authors:  Philip J Klemmer; W Chalermskulrat; Michael S Reif; Susan L Hogan; David C Henke; Ronald J Falk
Journal:  Am J Kidney Dis       Date:  2003-12       Impact factor: 8.860

Review 9.  Pharmacokinetic interactions with rifampicin : clinical relevance.

Authors:  Mikko Niemi; Janne T Backman; Martin F Fromm; Pertti J Neuvonen; Kari T Kivistö
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

10.  Pattern of acute poisonings in childhood in Ankara: what has changed in twenty years?

Authors:  Nesibe Andiran; Fikriye Sarikayalar
Journal:  Turk J Pediatr       Date:  2004 Apr-Jun       Impact factor: 0.552

View more
  2 in total

Review 1.  Drug Dosing in Patients Undergoing Therapeutic Plasma Exchange.

Authors:  Sherif Hanafy Mahmoud; Jessica Buhler; Eric Chu; Suzie A Chen; Theresa Human
Journal:  Neurocrit Care       Date:  2021-02       Impact factor: 3.210

2.  Effect of rifampicin on anticoagulation of warfarin: A case report.

Authors:  Ya-Ni Hu; Bo-Ting Zhou; Hua-Rong Yang; Qi-Lin Peng; Xu-Rui Gu; Shu-Sen Sun
Journal:  World J Clin Cases       Date:  2021-02-16       Impact factor: 1.337

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.